학술논문
S148: TIME-LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CLL WHO HAVE UNDETECTABLE MRD – 4-YEAR FOLLOW UP FROM THE RANDOMIZED PHASE II VISION/HO141 TRIAL
Document Type
article
Author
Arnon Kater; Julie Dubois; Christian Brieghel; Sabina Kersting; Lisbeth Enggaard; Gerrit Veldhuis; Rogier Mous; Clemens Mellink; Johan Dobber; Christian Poulsen; Caspar Da Cunha-Bang; Hendrik Fredriksen; Ann Janssens; Ida Schjodt; Ellen Dompeling; Juha Ranti; Mattias Mattsson; Mar Bellido; Hoa Tran; Kazem Nasserinejad; Mark-David Levin; Carsten Niemann
Source
HemaSphere, Vol 7, p e10648ed (2023)
Subject
Language
English
ISSN
2572-9241